ICON to Partner With US Govt Agency to Test COVID Vaccine Candidates
Contract research firm ICON said on Wednesday it is partnering with the US government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Contract research firm ICON said on Wednesday it is partnering with the US government for a clinical trial to test the effectiveness of next generation COVID-19 vaccine candidates.
When is stage III NSCLC resectable? Experts attempted to reach a consensus on when to perform surgery.
Antibody-drug conjugates link a tumor-targeted antibody to a cytotoxic drug through a chemical linker and hold the promise of high potency.
The two types of imaging catheter, as guides for coronary stent targeting and deployment, led to similar clinical outcomes in the OCTIVUS trial. A meta-analysis backed it up.
Submission is based on positive results from two phase 3, vehicle-controlled trials in patients ages 6 and older with mild to moderate AD.